Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.

Stadler WM, Desai AA, Quinn DI, Bukowski R, Poiesz B, Kardinal CG, Lewis N, Makalinao A, Murray P, Torti FM. A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):689-94.

View in: PubMed

collapse authors with profiles